- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 471/14 - Ortho-condensed systems
Patent holdings for IPC class C07D 471/14
Total number of patents in this class: 1973
10-year publication summary
|
134
|
137
|
107
|
145
|
159
|
162
|
168
|
201
|
169
|
62
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Merck Patent GmbH | 5909 |
64 |
| Intra-Cellular Therapies, Inc. | 378 |
54 |
| Incyte Corporation | 918 |
42 |
| Bristol-myers Squibb Company | 5080 |
39 |
| Shionogi & Co., Ltd. | 914 |
37 |
| Novartis AG | 11238 |
33 |
| Janssen Pharmaceutica N.V. | 3839 |
27 |
| Genentech, Inc. | 3742 |
24 |
| Gilead Sciences, Inc. | 1879 |
23 |
| Merck Sharp & Dohme LLC | 3689 |
22 |
| Vertex Pharmaceuticals Incorporated | 1581 |
20 |
| F. Hoffmann-La Roche AG | 7958 |
17 |
| Janssen Sciences Ireland Unlimited Company | 431 |
17 |
| Dana-Farber Cancer Institute, Inc. | 2455 |
15 |
| Takeda Pharmaceutical Company Limited | 2961 |
14 |
| Pfizer Inc. | 3322 |
13 |
| Amgen Inc. | 3779 |
13 |
| AC Immune S.A. | 234 |
13 |
| King Faisal University | 409 |
13 |
| Oncoceutics, Inc. | 28 |
13 |
| Other owners | 1460 |